CACTUS provides AI-powered cheminformatics for autonomous science.

PNNL scientists use proteomics to unveil how high-density lipoproteins protect against cholesterol accumulation in the artery wall.

A new database allows researchers to connect lattice parameters and composition in olivine.

New methodology can evaluate the potential for carbon storage and critical mineral recovery in undercharacterized geological settings.

Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.

PMedIC, the PNNL and OHSU joint research collaboration, contributes to student success and impact in biomedicine.

New research investigating water-lean solvents for carbon dioxide capture identifies the unique chemistry possible with their use, may lead to new design principles that move beyond single carbon capture.

Data reveals mechanisms in our bodies that can help us fight viral pathogenesis.

Pacific Northwest may face increase in summer heat-dome-like stationary waves.

Department of Energy’s Advanced Research Projects Agency-Energy selects PNNL project to help accelerate the development of marine carbon dioxide removal technologies.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

Metabolomics analysis revealed differences in metabolome profiles for two distinct modes of fungal wood decay.

COVID-19 infections at PNNL early in the pandemic were caused by a wide variety of viral sequences, according to a new analysis by Laboratory researchers.

Under Secretary for Science and Innovation at the Department of Energy Geri Richmond visited PNNL.

First-of-its-kind genomic catalog lends insight into previously unknown processes at the river’s edge.

Department of Energy, Office of Science Director Asmeret Asefaw Berhe visited PNNL to learn about the Lab’s drive to conduct discovery science, commitment to science for an equitable future, and development of a diversified STEM workforce.

Newly developed models can help rapidly optimize systems to meet the need for rapidly deployable commercial carbon capture.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.